Scholarlink

Abstract <p>Polynucleotide (PN) fillers are widely used for skin rejuvenation due to their regenerative properties; however, injection-related pain remains a major drawback. This randomized, patient-blinded, split-face study evaluated a novel “ionization-adjusted” PN filler with modified pH and ionic strength designed to reduce injection pain without compromising efficacy. Fifteen participants received 1&#xa0;mL of conventional PN filler on one side of the face and 1 mL of the ionized PN filler on the other. Pain was assessed using a 10-point Visual Analog Scale (VAS), while wrinkle improvement was evaluated using the Crow’s Feet Grading Scale (CFGS) and Global Aesthetic Improvement Scale (GAIS). The ionized PN filler demonstrated significantly lower pain scores (VAS 3.39 ± 1.81) compared to the conventional filler (VAS 5.04 ± 2.19, p &lt; 0.005), with fewer cases of erythema (40% vs. 60%) and embossing (13.3% vs. 56.7%). Both formulations showed significant improvements in CFGS and GAIS scores without statistical differences. These findings suggest that ionization-adjusted PN filler provides a more comfortable injection experience while maintaining similar clinical efficacy and safety profiles.</p> Level of Evidence I <p>This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors <a href="http://www.springer.com/00266">www.springer.com/00266</a>.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Efficacy of Ionization-Adjusted PN Filler in Minimizing Injection Pain: A Randomized, Patient-Blinded, Split-Face Study

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年12月8日

查看全文
  • Woosang Jeon,
  • Minwoo Park,
  • Sug Won Kim,
  • Jiye Kim

摘要

Abstract

Polynucleotide (PN) fillers are widely used for skin rejuvenation due to their regenerative properties; however, injection-related pain remains a major drawback. This randomized, patient-blinded, split-face study evaluated a novel “ionization-adjusted” PN filler with modified pH and ionic strength designed to reduce injection pain without compromising efficacy. Fifteen participants received 1 mL of conventional PN filler on one side of the face and 1 mL of the ionized PN filler on the other. Pain was assessed using a 10-point Visual Analog Scale (VAS), while wrinkle improvement was evaluated using the Crow’s Feet Grading Scale (CFGS) and Global Aesthetic Improvement Scale (GAIS). The ionized PN filler demonstrated significantly lower pain scores (VAS 3.39 ± 1.81) compared to the conventional filler (VAS 5.04 ± 2.19, p < 0.005), with fewer cases of erythema (40% vs. 60%) and embossing (13.3% vs. 56.7%). Both formulations showed significant improvements in CFGS and GAIS scores without statistical differences. These findings suggest that ionization-adjusted PN filler provides a more comfortable injection experience while maintaining similar clinical efficacy and safety profiles.

Level of Evidence I

This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.